Heat Shock Protein 22, human recombinant protein
HSPB8 H11 HMN2 CMT2L DHMN2, E2IG1, HMN2A, HSP22, Heat shock protein β-8, α-crystallin C chain, Smal
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q9UJY1 |
---|---|
Calculated MW | 22 kDa |
Gene ID | 26353 |
---|---|
Gene Symbol | HSPB8 |
Other Names | HSPB8 H11 HMN2 CMT2L DHMN2, E2IG1, HMN2A, HSP22, Heat shock protein β-8, α-crystallin C chain, Small stress protein-like protein HSP22, E2-induced gene 1 protein, Protein kinase H11, CRYAC, |
Gene Source | Human |
Source | E. coli |
Assay&Purity | SDS-PAGE; ≥98% |
Assay2&Purity2 | HPLC; ≥98% |
Recombinant | Yes |
Results | Confirmed |
Application Notes | Reconstitute in H20 to a concentration of 0.1-1.0 mg/ml. The solution can then be diluted to other aqueous buffers |
Format | Lyophilized protein |
Storage | -80°C; Sterile filtered and lyophilized with no additives |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Recombinant Human Heat Shock Protein is produced in E.Coli and purified by proprietary chromatographic techniques.
References
Charpentier A.H.,et al.Cancer Res. 60:5977-5983(2000).
Benndorf R.,et al.J. Biol. Chem. 276:26753-26761(2001).
Smith C.C.,et al.J. Biol. Chem. 275:25690-25699(2000).
Wiemann S.,et al.Genome Res. 11:422-435(2001).
Wan D.,et al.Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.